Avidity Biosciences, Inc. 4 SEC Filings

Filed On	Filing
27 Feb 2026	Form 4: McCarthy Teresa, Chief Human Resources Officer Returned 165,296 shares to the issuer · Disposed of 518,500 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Thompson Tamar, Director Returned 6,692 shares to the issuer · Disposed of 67,523 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: MacLean Michael F, Chief Financial Officer Returned 133,977 shares to the issuer · Disposed of 587,375 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Skerjanec Simona, Director Returned 6,692 shares to the issuer · Disposed of 52,342 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Hughes Steven George, Chief Medical Officer Returned 115,857 shares to the issuer · Disposed of 315,133 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Boyce Sarah, Director Returned 474,861 shares to the issuer · Disposed of 2,176,015 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Moriarty John B, Chief Legal Officer Returned 92,054 shares to the issuer · Disposed of 210,000 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Flanagan W. Michael, Chief Scientific Officer Returned 150,365 shares to the issuer · Disposed of 397,500 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Wilson Troy Edward, Director Returned 78,802 shares to the issuer · Disposed of 38,523 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Gallagher Kathleen P., Chief Program Officer Returned 80,303 shares to the issuer · Disposed of 208,330 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Henig Noreen, Director Returned 6,692 shares to the issuer · Disposed of 103,380 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Kim Jean Jinsun, Director Returned 6,692 shares to the issuer · Disposed of 97,523 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Levin Arthur A, Director Returned 147,934 shares to the issuer · Disposed of 295,523 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Kaye Edward M. Md, Director Returned 6,692 shares to the issuer · Disposed of 103,380 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Boess Carsten, Director Returned 6,692 shares to the issuer · Disposed of 103,381 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Mosbrooker Eric, Chief Commercial Officer Returned 79,413 shares to the issuer · Disposed of 227,188 Stock Option (Right to Buy) (Disposition to Issuer)
27 Feb 2026	Form 4: Calderaro Charles Iii, Chief Technical Officer Returned 98,547 shares to the issuer · Disposed of 80,000 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Hughes Steven George, Chief Medical Officer Sold 4,895 shares ($355K)
23 Jan 2026	Form 4: Boyce Sarah, Director Sold 14,387 shares ($1.04M)
23 Jan 2026	Form 4: Flanagan W. Michael, Chief Scientific Officer Sold 6,534 shares ($473K)

Comments